View recent announcements and news releases related to Providence ResearchTo read the full article, please click on the article title.
This past week, on International Overdose Awareness Day (August 31), communities across BC and Canada commemorated the thousands of lives lost to drug poisoning – and called for action to end policies that are creating harms around the world.
The BC-CfE’s Laboratory and its Director, Dr. Zabrina Brumme, are celebrating another recent success in being awarded grant funding for research. The BC-CfE, along with frequent collaborating partner Simon Fraser University, are now a part of the U.S.-based Research Enterprise to Advance a Cure for HIV (REACH) Collaboratory.
To improve emergency care for remote First Nations communities, the Nuu-chah-nulth Tribal Council (NTC) partnered with the University of British Columbia’s Department of Emergency Medicine to create Kwiis-hen-niip, meaning “change” in Nuu-chah-nulth.
Treatment of highly agitated or violent patients in the emergency department with ketamine is more effective than traditional approaches, and could be safer for patients and staff. These results are from an innovative clinical trial led by CHÉOS Scientist Dr. David Barbic and published this week in Annals of Emergency Medicine.
We have reached another major milestone for the new St. Paul's Hospital campus — the business plan for the Clinical Support and Research Centre (CSRC) has been approved by the provincial government.
Research by the BC Centre on Substance Use at St. Paul’s Hospital and other groups has received $770,000 to investigate the uptake, effectiveness and side effects of COVID-19 vaccines among vulnerable urban populations.
The Treatment Optimization of Psychosis (TOP) Collaborative is a partnership with the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul’s Hospital and Vancouver Coastal Health’s Mental Health and Substance Use Services.
People who use drugs are more likely than non-drug users to leave hospital before it is medically recommended, which is associated with a tripling of short-term mortality. A new study led by CHÉOS Scientist Dr. John Staples seeks to determine whether these deaths are the result of overdose and, if so, how they can be prevented.
Are there opioids in your medicine cabinet? Probably. One in five of Canadians has been prescribed long-term opioids; 25% of those prescriptions are for doses that fall into the danger zone for addiction. When we think of people living with opioid addiction, it’s the mirror on the medicine cabinet that reminds us we are all vulnerable.
Why do some people infected with the virus that causes COVID-19 get severe disease while others have no symptoms? Why do some experience long-term effects and others recover quickly? These are some of the questions that a new study, launching this week at St. Paul’s Hospital, aims to answer.